Last $2.04 USD
Change Today +0.24 / 13.33%
Volume 300.0
As of 8:10 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

iris biotechnologies inc (IRSB) Snapshot

Open
$2.04
Previous Close
$1.80
Day High
$2.04
Day Low
$2.04
52 Week High
06/18/14 - $4.50
52 Week Low
10/25/13 - $0.20
Market Cap
30.5M
Average Volume 10 Days
623.6
EPS TTM
$-0.05
Shares Outstanding
15.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IRIS BIOTECHNOLOGIES INC (IRSB)

Related News

No related news articles were found.

iris biotechnologies inc (IRSB) Related Businessweek News

No Related Businessweek News Found

iris biotechnologies inc (IRSB) Details

Iris BioTechnologies Inc., a development stage life science company, focuses on developing solutions for the detection and monitoring of monogenic and complex genomic diseases. It focuses on the development and commercialization of a nano-biochip gene expression kit using a convergence of scientific disciplines in nanotechnology, semiconductor manufacturing, microfluidics, chemistry, molecular biology, genetics, genomics, and information technology; and BioWindows, an artificial intelligence system, which includes a database comprising data fields for patient demographic information, personal and family medical history, and gene expression information. The company also intends to use its product platform to diagnose and treat patients with breast cancer, neurological disorders, heart disease, diabetes, and other gene-related metabolic problems. In addition, it is working on gene markers for CancerChip and specific markers associated with prostrate, lung, liver, kidney, and ovarian cancers, as well as genes associated with schizophrenia, Alzheimer disease, autoimmune system disorders, and metabolic and drug metabolism disorders. The company was founded in 1999 and is headquartered in Santa Clara, California.

7 Employees
Last Reported Date: 03/31/14
Founded in 1999

iris biotechnologies inc (IRSB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

iris biotechnologies inc (IRSB) Key Developments

Iris BioTechnologies Inc. Presents at BIO International Convention, Jun-24-2014 03:15 PM

Iris BioTechnologies Inc. Presents at BIO International Convention, Jun-24-2014 03:15 PM. Venue: San Diego Convention Center, San Diego, California, United States.

Iris BioTechnologies Inc. Appoints Paul Yaswen as Chief Scientific Officer

On October 27, 2013, Iris BioTechnologies Inc. appointed Paul Yaswen, Ph.D. as Chief Scientific Officer of the company. In this role, he will have broad responsibilities in scientific research and launching new products. Dr. Yaswen has over two decades of experience performing breast cancer research at the Lawrence Berkeley National Laboratory.

Iris BioTechnologies Inc. Announces Auditor Changes

Iris BioTechnologies Inc. announced that Russell Bedford Stefanou Mirchandani LLP was disengaged as the independent registered public accounting firm of the company. On February 21, 2013, the Board of Directors approved the appointment of Fiondella, Milone & Lasaracina, LLP as the independent registered public accounting firm of the Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRSB:US $2.04 USD +0.24

IRSB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IRSB.
View Industry Companies
 

Industry Analysis

IRSB

Industry Average

Valuation IRSB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 230.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIS BIOTECHNOLOGIES INC, please visit www.irisbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.